ARCHIVES

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

This article is from The Cancer Letter archive.

Vol. 34 No. 4 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

Weak Structure, Deficiencies, Cited In Dana-Farber Reviews

November 3, 1995

Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO

May 25, 2007

NCI May Ask Grantees To Assume Additional Services, Broder Says

November 11, 1994

In Congress: Human Genome Project Ahead Of Schedule, Collins Assert

March 27, 1998

ASCO, COA Present Plans For Cancer CareBeyond the Fee-For-Service Pay Structure

January 24, 2014

NIH Director Collins Publishes Third Book About Faith In God

March 5, 2010